The ASAM National Practice Guideline on Medications to Treat Opioid Use Webinar (1 Credit)
Recorded On: 12/10/2015
- Registration Closed
An archived recording of the webinar is available NOW.
The ASAM National Practice Guideline for Use of Medications in the Treatment of Addiction Involving Opioid Use was developed to promote evidence-based clinical treatment of opioid use disorder and to assist physicians in the decision-making process for prescribing pharmacotherapies to patients with opioid use disorder.
Methodology: The guideline was developed with support from Treatment Research Institute (TRI) using a modified RAND/UCLA Appropriateness Method (RAM), a process that combines scientific evidence and clinical knowledge to determine the appropriateness of a set of clinical procedures. A Guideline Committee comprised of ten experts from multiple disciplines, including internal medicine, addiction medicine, psychiatry, pain medicine and obstetrics/gynecology, reviewed treatment scenarios and assisted in the development and writing of the guideline.
Instructions: Register for the upcoming 1 hour webinar. Join the webinar at the designated time. Upon completion of the webinar, answer the test questions for CME credit.
This webinar is primarily intended for clinicians involved in evaluating patients and providing authorization for pharmacological treatments at any level.
CME & MOC Information and Disclosure Listing
The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This course has been designated as an approved CME Activity by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 1 AMA PRA Category 1 Credit(s)™ to the CME requirement for Part II: Lifelong Learning and Self-Assessment.
In accordance with the disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the CME Committee, Planning Committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All CME Committee, Planning Committee and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the content of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
ASAM CME Committee Disclosure Information:
Nature of Relevant Financial Relationship
What was received?
For what role?
Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair
Catherine Friedman, MD
Noel Ilogu, MD, MRCP
Hebert L. Malinoff, MD, FACP, DFASAM, Reviewer
Edwin A. Salsitz, MD, DFASAM, Reviewer
John C. Tanner, DO, DFASAM
Speaker and Consultant
Planning Committee and Faculty
|Name||Commercial Interest||What was received?||For what role?|
|Chinazo Cunningham, MD, MS, FASAM||Quest Diagnostics||Stock||Employment|
|Adam J. Gordon, MD, MPH, DFASAM, FACP||None|
|Margaret A. E. Jarvis, MD, DFASAM|
Geisinger Health System
US Prevention Health
Hoffspiegel and Associates
|Kyle Kampman, MD|
|Robert Roose, MD, MPH||Health New England, Inc.||Honoraria||Behavioral Health Advisory Committee, Associate Medical Director|
Dr. Margaret A.E. Jarvis, MD, DFASAM
Chief, Addiction Medicine, Geisinger
Margaret Jarvis finished her medical school, psychiatry residency and Addiction Medicine Fellowship at the Medical College of Virginia in Richmond. She is board certified and recertified in psychiatry with the CAQ in Addiction Psychiatry. She was ASAM certified (now ABAM certified). She has been a member of ASAM since the early 90’s and became a Fellow of the Society in 2003. She has served on the Board of Directors for one term and currently is the co-chair of the Ruth Fox Planning; and a member of the Finance Committee and the Constitution and Bylaws Committee. She has also worked on Examination Committee for ASAM and now ABAM since 2000.
Dr. Jarvis is the Medical Director at Marworth, in Waverly, PA, which is the residential addiction treatment center for the Geisinger Health System. She has been in this position since 1999. She is also Clinical Assistant Professor of Psychiatry at the Penn State University College of Medicine in Hershey, PA.
Dr. Jarvis is a member of the Society for the Advancement of Sexual Health, a professional organization of therapists who treat sexual addiction, and served on that board of directors from 2001-2006, as president from 2004-2006. She received the Merit award from SASH in 2011. Dr. Jarvis currently serves as the Treasurer of the Board of Marley’s Mission, a non-profit that provides equine-assisted psychotherapy to abused children in the Scranton, PA area.
MD, FASAM, MS
Chinazo Cunningham, MD, FASAM, MS has spent over a decade providing care, developing programs, and conducting research focused on marginalized populations including drug users, HIV-infected individuals, and the unstably housed.
Dr. Kyle M. Kampman, MD
Professor, Perelman School of Medicine
Dr. Kyle Kampman graduated from Northwestern University in 1981 and Tulane University School of Medicine in 1985. He interned at the National Naval Medical Center at Bethesda Maryland and served in the United States Navy from 1985 until 1990. He came to the University of Pennsylvania and served as a resident in psychiatry from 1990 until 1993. He then completed a fellowship in Addiction Psychiatry. In 1994 he joined the faculty in the Department of Psychiatry as an assistant professor. He was promoted to associate professor in 2003 and to professor in 2012. Dr. Kampman has had extensive experience in the treatment of alcohol cocaine and opiate dependence. He has conducted a number of trials testing medications for the treatment of cocaine alcohol and opiate dependence and is a recognized authority on the cocaine withdrawal syndrome. In addition to research, he works at the Addiction Recovery Unit of the Philadelphia VA Medical Center where he continues to treat cocaine, alcohol and opiate dependent patients with both medications and psychotherapy.
MD, MPH, FASAM
Robert Roose, MD, MPH, FASAM is currently the Chief Medical Officer of Addiction Services for the Sisters of Providence Health System (SPHS). Dr. Roose is on the Quality Improvement Council of ASAM, the Substance Use Disorder Prevention and Treatment Task Force of the Massachusetts Hospital Association, and Massachusetts Governor Baker's Opioid Addiction Working Group. He has presented and published on various aspects of addiction treatment, focusing primarily on patients receiving medication-assisted treatment for opioid use disorder, and his work integrating Hepatitis C treatment and a peer program into an opioid treatment program is also featured in an award-winning documentary.
Previously, Dr. Roose served as Director of Quality Improvement for the Division of Substance Abuse at Albert Einstein College of Medicine in the Bronx, NY, where he also served as Medical Director of the Melrose Wellness Center and Assistant Professor in the Departments of Family & Social Medicine and Psychiatry & Behavioral Sciences. Board-certified in both Family Medicine and Addiction Medicine, Dr. Roose was named the 2012 Addiction Medicine Physician of the Year by the New York State Department of Health's Office of Alcoholism and Substance Abuse Services. Dr. Roose earned his Doctor of Medicine and Master in Public Health degrees at George Washington University School of Medicine and Health Sciences in Washington D.C.